Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani
- 1 December 2017
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 105, 625-637
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research
This publication has 39 references indexed in Scilit:
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisJournal of Antimicrobial Chemotherapy, 2012
- DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING HPLC METHOD FOR ANALYSIS OF ZIDOVUDINE (ZDV) IN BULK DRUG AND IN VITRO RELEASE STUDIES OF TABLETSJournal of Liquid Chromatography & Related Technologies, 2011
- Effects of Surfactants and Lipids on the Preparation of Solid Lipid Nanoparticles Using Double Emulsion MethodJournal of Dispersion Science and Technology, 2011
- Amphotericin B inhibits entry of Leishmania donovani into primary macrophagesBiochemical and Biophysical Research Communications, 2010
- Lipid nanoparticles for alkyl lysophospholipid edelfosine encapsulation: Development and in vitro characterizationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: Active ingredient and mediator of drug releaseJournal of Controlled Release, 2008
- Biodegradable nanoparticles for cytosolic delivery of therapeutics☆Advanced Drug Delivery Reviews, 2007
- Advances in leishmaniasisThe Lancet, 2005
- Anti‐leishmanial activity of a new formulation of amphotericin BTropical Medicine & International Health, 2004
- Receptor-mediated stimulatory effect of oligochitosan in macrophagesBiochemical and Biophysical Research Communications, 2004